Evidence map›Paper›PMID 38130828›Full record

ArticleNeurology. Genetics2024

Parkinson Disease Genetics Extended to African and Hispanic Ancestries in the VA Million Veteran Program.

Nathan Pankratz, Benjamin R Cole, Kathleen M Beutel, Katherine P Liao, James Ashe

Open access · goldAbstract read
In one paragraph

Article in Neurology. Genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Validation of Parkinson's Disease Ascertainment in the Veterans Administration Electronic Medical Record.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Nathan PankratzFrom the Department of Laboratory Medicine and Pathology (N.P., B.R.C., K.M.B.), School of Medicine, University of Minnesota, Minneapolis; Division of Rheumatology (K.P.L.), Immunology, and Allergy, Brigham and Women's Hospital; Department of Biomedical Informatics (K.P.L.), Harvard Medical School; Division of Data Sciences (K.P.L.), VA Boston Healthcare System, MA; Department of Neurology (J.A.), University of Minnesota Medical School; and Department of Neurology (J.A.), Minneapolis Veterans Affairs Health Care System, MN.
Benjamin R ColeFrom the Department of Laboratory Medicine and Pathology (N.P., B.R.C., K.M.B.), School of Medicine, University of Minnesota, Minneapolis; Division of Rheumatology (K.P.L.), Immunology, and Allergy, Brigham and Women's Hospital; Department of Biomedical Informatics (K.P.L.), Harvard Medical School; Division of Data Sciences (K.P.L.), VA Boston Healthcare System, MA; Department of Neurology (J.A.), University of Minnesota Medical School; and Department of Neurology (J.A.), Minneapolis Veterans Affairs Health Care System, MN.
Kathleen M BeutelFrom the Department of Laboratory Medicine and Pathology (N.P., B.R.C., K.M.B.), School of Medicine, University of Minnesota, Minneapolis; Division of Rheumatology (K.P.L.), Immunology, and Allergy, Brigham and Women's Hospital; Department of Biomedical Informatics (K.P.L.), Harvard Medical School; Division of Data Sciences (K.P.L.), VA Boston Healthcare System, MA; Department of Neurology (J.A.), University of Minnesota Medical School; and Department of Neurology (J.A.), Minneapolis Veterans Affairs Health Care System, MN.
Katherine P LiaoFrom the Department of Laboratory Medicine and Pathology (N.P., B.R.C., K.M.B.), School of Medicine, University of Minnesota, Minneapolis; Division of Rheumatology (K.P.L.), Immunology, and Allergy, Brigham and Women's Hospital; Department of Biomedical Informatics (K.P.L.), Harvard Medical School; Division of Data Sciences (K.P.L.), VA Boston Healthcare System, MA; Department of Neurology (J.A.), University of Minnesota Medical School; and Department of Neurology (J.A.), Minneapolis Veterans Affairs Health Care System, MN.ORCID https://orcid.org/0000-0002-4797-3200
James AsheFrom the Department of Laboratory Medicine and Pathology (N.P., B.R.C., K.M.B.), School of Medicine, University of Minnesota, Minneapolis; Division of Rheumatology (K.P.L.), Immunology, and Allergy, Brigham and Women's Hospital; Department of Biomedical Informatics (K.P.L.), Harvard Medical School; Division of Data Sciences (K.P.L.), VA Boston Healthcare System, MA; Department of Neurology (J.A.), University of Minnesota Medical School; and Department of Neurology (J.A.), Minneapolis Veterans Affairs Health Care System, MN.
Brigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Nearly all genetic analyses of Parkinson disease (PD) have been in populations of European ancestry. We sought to test the ability of a machine learning method to extract accurate PD diagnoses from an electronic medical record (EMR) system, to see whether genetic variants identified in European populations generalize to individuals of African and Hispanic ancestries, and to compare the rates of PD across ancestries. Methods: A machine learning method using natural language processing was applied to EMRs of US veterans participating in the VA Million Veteran Program (MVP) to identify individuals with PD. These putative cases were vetted via blind chart review by a movement disorder specialist. A polygenic risk score (PRS) of 90 established genetic variants whose genotypes were imputed from a customized Axiom Biobank Array was evaluated in different case groups. Results: The EMR prediction scores had a distinct trimodal distribution, with 97% of the high group and only 30% of the middle group having a credible diagnosis of PD. Using the 3,542 cases from the high group matched 4:1 to controls, the PRS was highly predictive in individuals of European ancestry (n = 3,137 cases; OR = 1.82; Discussion: Machine learning can reliably classify PD using data from a large EMR. Larger studies of non-European populations are required to confirm the generalizability of PD risk variants identified in populations of European ancestry and the increased risk coming from a higher proportion of European DNA in African Americans.

Identifiers

PMID38130828
PMCPMC10732342
OpenAlexW4390021925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.